epigallocatechin gallate has been researched along with Heart Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Huang, L; Luo, X; Mao, Q; Peng, C; Wu, S; Zhang, H | 1 |
| Huang, X; Jia, Z; Liu, L; Luo, M; Mou, Q; Quan, J; Tian, J | 1 |
| Chen, K; Chen, W; Han, Y; Hou, P; Huang, XY; Liu, SL; Qi, J; Wang, Y; Wu, TS; Yao, H; Yu, KF | 1 |
| Gan, Y; Liu, J; Liu, L; Tian, J; Zhao, W | 1 |
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
5 other study(ies) available for epigallocatechin gallate and Heart Failure
| Article | Year |
|---|---|
EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.
Topics: Acetylation; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Catechin; Constriction; Disease Models, Animal; Electrocardiography; Heart Failure; Histone Deacetylases; Histones; Lysine; Male; MEF2 Transcription Factors; Natriuretic Peptide, Brain; Survival Rate; Ventricular Remodeling | 2022 |
Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Energy Metabolism; Heart Failure; Myocardium; Rats; Reproducibility of Results | 2022 |
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
Topics: Animals; Apoptosis; Biomarkers; Catechin; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice; Myocardium; Oxidative Stress; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ultrasonography | 2018 |
Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
Topics: Acetylation; Animals; Aortic Diseases; Cardiovascular Agents; Catechin; Constriction, Pathologic; Disease Models, Animal; Heart Failure; Histone Deacetylase 1; Histones; Male; Mice, Inbred C57BL; Promoter Regions, Genetic; Protective Agents; Random Allocation; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Up-Regulation | 2018 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |